Iron supplements (IronFlow) capsules containing ferrous and ferric iron to aid oxygen transport
Patent Information
- Application Number
- TW115204425
- Authority / Receiving Office
- TW · TW
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2026-05-18
- Publication Date
- 2026-11-01
- Estimated Expiration
- 2036-05-17
Smart Images

Figure TWG2TB001919466_001 
Figure TWG2TB001919466_002 
Figure TWG2TB001919466_003
Abstract
Claims
1. A capsule containing iron (Fe2+ and Fe3+) composition that aids in oxygen transport, characterized in that the capsule comprises: A capsule body is provided with a left shell and a right shell respectively, which are connected and form a receiving chamber inside; a plurality of particles are installed in the receiving chamber of the capsule body, and the particles are composed of: ferric pyrophosphate of ferric trivalent iron and ferrous glycinate of ferrous divalent iron as an iron agent (IronFlow) and a combination of active folic acid, vitamin B12, long-acting vitamin B1 and vitamin C.
2. The IronFlow composition capsule containing ferrous and ferric iron as described in claim 1, which aids in oxygen transport, wherein, The particulate matter contains the composition further enriched with piperine to improve bioavailability.
3. A capsule containing an iron supplement (IronFlow) composition that aids in oxygen transport, comprising ferrous and ferric iron as described in claim 1 or 2, wherein, The particulate matter contains ferrous glycine of the divalent iron in the composition, which forms a stable small molecular structure by chelating one divalent ferrous ion with two glycine molecules.
